Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Zhang, Xinmei, Yeung, Dennis C.Y., Karpisek, Michal, Stejskal, David, Zhou, Zhi-Guang, Liu, Feng, Wong, Rachel L.C., Chow, Wing-Sun +3 more·2008·Diabetes
DOI 10.2337/db07-1476

Cited by (907)

Items 801–900 of 907

  1. First evaluation of fibroblast growth factor 21 levels in patients diagnosed with glycogen storage diseases with liver involvement
    A BOZKURT, Esra Kara, Fatma Derya Bulut, İrem Kaplan, Ezgi Burgaç, Burcu Köşeci, Nazmiye Tüzel Gündüz, Gülçin Dağlıoğlu, Gülşah Şeydaoğlu, Neslihan Önenli Mungan et al. · 2025 · Journal of Pediatric Endocrinology and Metabolism
  2. New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling
    Michaela Hvizdak, Sylvie E. Kandel, Jed Noah Lampe · 2026 · Chemical Research in Toxicology
  3. Adipokine: Rolle in der Pathophysiologie und Therapie von Adipositas und Typ 2 Diabetes mellitus / Adipokines: Role in the pathophysiology and therapy of obesity and type 2 diabetes
    Mathias Faßhauer, Matthias Blüher · 2009 · Journal of Laboratory Medicine
  4. Butyric Acid Influences How β-Hydroxybutyrate Modulates Fatty Acid Oxidation and Ketogenesis To Support Ketosis
    Franco Cavaleri · 2018 · Current Research in Diabetes & Obesity Journal
  5. Ağırlık Yönetiminde Omega-3 Çoklu Doymamış Yağ Asitlerinin Rolü
    Ramazan Mert Atan, Nihal Zekiye Erdem · 2021 · Journal of Nutrition and Dietetics
  6. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort
    Rui Zhang, Yufeng Li, Xianghai Zhou, Fang Zhang, Meng Li, Simin Zhang, Xiuying Zhang, Xin Wen, Linong Ji · 2021 · Medicine
  7. Temas de actualidad en prevención cardiovascular y rehabilitación cardiaca
    Montserrat León-Latre, Pilar Mazón‐Ramos, Esther Marcos, Esteban García-Porrero · 2009 · Revista Española de Cardiología Suplementos
  8. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype
    Dorota Wesół‐Kucharska, Dariusz Rokicki, Milena Greczan, Magdalena Kaczor, Edyta Czekuć-Kryśkiewicz, Dorota Piekutowska‐Abramczuk, Paulina Halat-Wolska, Elżbieta Ciara, Maciej Jaworski, Aleksandra Jezela‐Stanek · 2022 · Pediatric Endocrinology Diabetes and Metabolism
  9. Association between Plasma FGF21 Levels and Body Composition in Patients with Gastric Cancer
    Yingjing Zhang, Lin Jiang, Pengfei Su, Zhiqiang Ma, Weiming Kang, Xin Ye, Yuqin Liu, Jianchun Yu · 2022 · Nutrition and Cancer
  10. Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial
    Johannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, Roland Feldbauer, Klemens Rosenberger, Michael Resl, Thomas Wagner, Florian Obendorf, Margot Egger-Salmhofer, Benjamin Dieplinger et al. · 2022 · Journal of Cellular and Molecular Medicine
  11. Growth factors reviews
    Xiaokun Li · 2024 · Elsevier eBooks
  12. Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto’s Thyroiditis on Levothyroxine Substitution
    Eszter Berta, Sándor Halmi, István Molnár, Dávid Hutkai, Sára Csiha, Harjit Pal Bhattoa, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi et al. · 2024 · Metabolites
  13. Circulating FGF21 is lower in South Asians compared with Europids with type 2 diabetes mellitus
    Carlijn A. Hoekx, Borja Martínez‐Téllez, Maaike E. Straat, Maurice B. Bizino, Huub J. van Eyk, Hildebrandus J. Lamb, Johannes W. A. Smit, Ingrid M. Jazet, Kimberly J. Nahon, Laura G.M. Janssen et al. · 2024 · Endocrine Connections
  14. Fibroblast growth factor 21 in patients with mild autonomic cortisol secretion and non-functioning adrenal incidentalomas
    Lucyna Siemińśka, Katarzyna Siemińska, Anna Dittfeld, Agnieszka Kotecka-Blicharz · 2024 · Endokrynologia Polska
  15. Fibroblast Growth Factor 21 (FGF21), Free Fatty Acid (FFA), High Sensitivity C-reactive Protein (hsCRP) and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Among Indonesian Obese Non-Diabetic Males
    Yani Lina, Gatot Susilo Lawrence, Andi Wijaya, Suryani As’ád · 2009 · The Indonesian Biomedical Journal
  16. FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
    Andrew J. Whittle · 2016 · Endocrinology
  17. HLA-B*60 and HLA-DR*14 Alleles might be associated with the Hyperuricemic and Possibly Metabolic Syndrome Status in Renal Transplant
    Gabriela Hernández‐Molina · 2016 · Journal of Clinical Nephrology and Renal Care
  18. Protein Structure and Modification of FGFs
    Xiaokun Li · 2018 · Elsevier eBooks
  19. Pathophysiology and Pharmacology of FGFs
    Xiaokun Li · 2018 · Elsevier eBooks
  20. Micro RNA in Degenerative Disorders
    azza naggar · 2019 · Zagazig Veterinary Journal/Zagazig Veterinary Journal (Online)
  21. Reduced fibroblast growth factor 21 and β-Klotho secretion in untreated congenital isolated GH deficiency
    Alécia A. Oliveira‐Santos, Roberto Salvatori, Ana Carolina Bueno, Mônica Cristina Nogueira, Viviane C. Campos, Manuela A. Melo, Carla R. P. Oliveira, Cynthia S. Barros-Oliveira, Cindi G. Marinho, Nayra Prata Damascena et al. · 2021 · Endocrine
  22. Translation Reprogramming as a Novel Therapeutic Target in MAFLD
    Mayada Metwally, Thomas Berg, Emmanuel A. Tsochatzis, Mohammed Eslam · 2022 · Advanced Biology
  23. Investigation of the Proliferative Potential of FGF21 or FGF19 in Liver-Specific FGFR4-Deficient Mice
    Kerstin Wäse, Thomas Bartels, Uwe Schwahn, Mostafa Kabiri · 2023 · Toxicologic Pathology
  24. Serum FGF21 levels are altered with various factors including lifestyle behaviors
    Kaori Nakanishi, Chisaki Ishibashi, Seiko Ide, Ryohei Yamamoto, Makoto Nishida, Izumi Nagatomo, Toshiki Moriyama, Keiko Yamauchi‐Takihara · 2021 · Research Square
  25. Author response: FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis
    Cong Liu, Milena Schönke, Borah Spoorenberg, Joost M. Lambooij, Hendrik J.P. van der Zande, Enchen Zhou, Maarten E. Tushuizen, Anne‐Christine Andréasson, Andrew Park, Stephanie N. Oldham et al. · 2023 · eLife
  26. The role of metabolic hormone Fibroblast Growth Factor 21 (FGF21) in mammalian hibernation using transgenic ground squirrels
    Bethany Theresa Nelson · 2012 · University of Minnesota Digital Conservancy (University of Minnesota)
  27. Growth and Growth Factors
    Elena Inzaghi, Stefano Cianfarani · 2018 · Yearbook of pediatric endocrinology
  28. REGULATORS OF GLUCOSE AND LIPID METABOLISM IN SKELETAL MUSCLE AND SERUM IMPLICATIONS FOR OBESITY AND TYPE 2 DIABETES
    Fredirick L. Mashili · 2012 · Figshare
  29. Association between Serum Fibroblast Growth Factor-21 Levels and Nonalcoholic Fatty Liver in Korean Men with Type 2 Diabetes
    Yong Jae Han, Ji Hye Huh, Jae Ho Seong, Jung Soo Lim, Mi Young Lee, Choon Hee Chung, Jang Yel Shin · 2015 · Korean Journal of Medicine
  30. The Relationship of Serum Fibroblast Growth Factor 21 Levels to Intima-Media Thickness in Dyslipidemic
    David Karásek, M Krsková, Milan Halenka, J. Orság · 2014
  31. IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY
    Bethany Theresa Nelson · 2012
  32. Immunological and molecular mechanisms in NAFLD
    Ionel Copaci, Laurenţiu Micu, Grethi Chiriac, Eugenia Mindrut, Gener Ismail, Luminiţa Leurzeanu · 2015 · Journal of Translational Medicine and Research
  33. Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease
    Samer Gawrieh, Naga Chalasani · 2015 · Springer eBooks
  34. The Role of Angiopoietin-like Protein 3 and Fibroblast Growth Factor 21 to Lipolysis, Inflammation and Insulin Resistance in Indonesian Non-Diabetic Obese Male
    Yani Lina, Gatot Susilo Lawrence, Andi Wijaya, Suryani As’ád · 2010 · The Indonesian Biomedical Journal
  35. CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
    Jody R. Dushay, Patricia C. Chui, Gosala S. Gopalakrishnan, Meghan B. Crawley, ffolliott Martin Fisher, Michael K. Badman · 2010
  36. Anti-human fibroblast growth factor-21 monoclonal antibody preparation, characterization and analysis of in vitro bioactivity
    Liangjun Ding, Zhichao Hao, Qingyan Yuan, Pengfei Xu, Yin-Hang Yu, Deshan Li · 2016 · Experimental and Therapeutic Medicine
  37. Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated
    Xin-min Wu, Qi Feng · 2015
  38. Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
    Thomas E. Akie · 2015 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  39. Diet-induced phenotypic plasticity during aging
    Fenni Rusli · 2016
  40. Harnessing the Action of Fibroblast Growth Factor21 as a Therapeutic Agent
    Luigi Brunetti, Leonid Kagan · 2017 · Current Pharmacology Reports
  41. Molecular Regulation of Gluconeogenesis by the Nuclear Receptors GR and LXRβ
    Rucha Patel · 2015 · TSpace (University of Toronto)
  42. Effects of Hydroalcoholic Extract of Sargassum Oligocystum on Serum Concentration of SIRT1 and FGF21 in Streptozotocin Induced Diabetic Rat
    Vida Soltani, Ali Movahed, Afshar Bargahi, Gholamreza Khamisipour, Afshin Ostovar, Adel Daneshi, Samad Akbarzadeh · 2018 · Iranian South Medical Journal
  43. Fibroblast Growth Factor 21 is a Novel Protein Sensor in Pregnancy
    Elizabeth F. Sutton · 2017
  44. Role of Fsp27 in lípid homeostasis during nutrient deprivation
    Alexandra Carrilho do Rosario · 2018 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  45. Exercise habits and ageing health : exploring the associations of FGF21 and lung microbiome in glycaemic regulation, bone health, arterial stiffness and respiratory health
    Shuen Yee Lee · 2020
  46. Effect of non-surgical periodontal treatment on crevicular levels of Chemerin and Fibroblast growth factor 21 in controlled type 2 diabetic and non-diabetic patients both with periodontitis and their glycemic control. A clinical trial
    Wesam Abdel Moneim, Olfat Gamil Shaker, Eman Mohammad Amr · 2019 · Egyptian Dental Journal /Egyptian Dental Journal
  47. Is ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis change the adiponectin and fibroblast growth factor‐21 levels?—Pilot study
    Rafał Kierach, Krzysztof Dąbrowski, Beniamin Oskar Grabarek, Marta Kojs‐Mrożkiewicz, Dariusz Boroń · 2020 · Dermatologic Therapy
  48. Intestinal-derived FGF15 preserves muscle and bone mass following sleeve gastrectomy
    Nadejda Bozadjieva-Kramer, Jae Hoon Shin, Yikai Shao, Ruth Gutiérrez‐Aguilar, Ziru Li, Kristy M. Heppner, Samuel Chiang, Sara G. Vargo, Katrina Granger, Darleen A. Sandoval et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the FGF21 locus
    Ali Bayoumi · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  50. Association of circulating oxidized LDL-C/LDL-C ratio with severity of coronary atherosclerosis and other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes
    Bo Feng · 2021 · Research Square
  51. Development of a fibroblast growth factor 21 assay
    Gabriela V. Tamassia · 2017
  52. High Circulating Fibroblast Growth Factor-21 Levels as a Prognostic Marker in Fatty Pancreas Patients
    Fei Han, Ling Yin, Xiaoping Yu, Renyan Xu, Mingxiang Tian, Xinnong Liu, Lu Zhou, Liang‐Hao Hu, Weijuan Gong, Weiming Xiao et al. · 2022 · Research Square
  53. Current literature in diabetes
    2008 · Diabetes/Metabolism Research and Reviews
  54. Faculty Opinions recommendation of Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome.
    Carlos Alberto Aguilar-Salinas · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  55. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects
    Qing‐Ri Jin, Yukiko Bando, Katsuyuki Miyawaki, Yosuke Shikama, Chisato Kosugi, Nanako Aki, Makoto Funaki, Sumihare Noji · 2000 · The Journal of Medical Investigation
  56. Correlation of Fibroblast Growth Factor 21 (FGF-21) with Fetal and Maternal Complications in Patients with Gestational Diabetes Mellitus
    Mohamed Reda Halawa, Magdy Hassan Kolaib, Ola Mohamed Mostafa Shaheen, Dina Ahmed Marawan, Salah Hussein Elhalawany · 2022 · The Egyptian Journal of Hospital Medicine
  57. Peer Review #3 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  58. Peer Review #1 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  59. Peer Review #2 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  60. Precision nutrition for cardiometabolic health: insights from human dietary intervention studies
    Anouk Gijbels · 2023
  61. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis
    Noriko Takebe, Yutaka Hasegawa, Yuriko Matsushita, Hiraku Chiba, Ken Onodera, Hirofumi Kinno, Tomoyasu Oda, Kan Nagasawa, Toshie Segawa, Yoshihiko Takahashi et al. · 2023 · Medicine
  62. Serum fibroblast growth factor-21 levels and its relationship with carotid intima-media thickness in type 1 diabetes mellitus patients
    Hatice Çalışkan, Mehmet Yaşar, Dilek Yazıcı, Oğuzhan Deyneli · 2023 · Marmara medical journal
  63. Doença hepática gordurosa não alcoólica em pacientes com diabetes mellitus tipo 2
    Mauy Frujuello Mana · 2021
  64. Impacto da superexpressão do receptor de estrogênio alfa sobre a resistência hepática à insulina e o metabolismo energético do fígado
    Ester S. Alves · 2023
  65. Signaling pathway and pharmacology
    Xiaokun Li · 2024 · Elsevier eBooks
  66. Others
    Xiaokun Li · 2024 · Elsevier eBooks
  67. Assessment of retinol-binding protein-4, fibroblast growth factor-21, and dipeptidyl peptidase-4 in relation to obesity and insulin resistance of type 2 diabetes mellitus among Egyptian patients
    Ayat I. Ghanem, Atef Bassyouni, GhadaA Omar · 2021 · Journal of The Arab Society for Medical Research
  68. FGF21 reflects a responsive adipose tissue-liver axis in both cardiometabolic burden and following metabolic surgery
    Marie Patt, Isabel Karkossa, Laura Krieg, Lucas Massier, Kassem Makki, Shirin Tabei, Thomas Karlas, Arne Dietrich, Martin T. Gericke, Michael Stümvoll et al. · 2024 · medRxiv
  69. Impact of 4-week endurance and resistance training on level of insulin resistance and FGf21 in heart tissue of diabetic male rats
    Sara Zare Karizak · 2024 · Comparative Clinical Pathology
  70. A comparison of brown fat tissue related hormone levels in metabolically healthy and unhealthy individuals with obesity
    Hacer Hicran Mutlu, Saniye Ada, Mehmet Uzunlulu, Hasan Hüseyin Mutlu, Mehmet Sargın, Aytekin Oğuz · 2024 · Endocrine
  71. The Effect of Endotoxin‐Induced Inflammation on the Activity of the Somatotropic Axis in Sheep
    Maciej Wójcik, Dorota Anna Zieba, Joanna Bochenek, Agata Krawczyńska, Marcin Barszcz, Alina Gajewska, Hanna Antushevich, Andrzej Przemysław Herman · 2024 · International Journal of Inflammation
  72. Correlations of Anthropometric and Body Composition Parameters with Fibroblast Growth Factor-21 Gene Expression in Peripheral Blood Mononuclear Cells of Healthy Young Adults
    Mahboobeh Mirhoseini, Ghazaleh Eslamian, Arman Ghorbani, Hamid Zand, Ebrahim Vasheghani‐Farahani · 2024 · Iṭṭilā’āt-i māhiyānah.
  73. Relationship Between Circulating FGF21 and Physiological and Lifestyle Characteristics, an Exploratory Study
    Matthew N. Peterson, Kathleen E. Adair, LesLee Funderburk · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  74. The effect of obesity on FibroScan parameters, cytokeratin-18, and fibroblast growth factor-21 levels
    Murat Keskın, Nizameddin Koca · 2025 · The European Research Journal
  75. Exploring impacts of long-COVID-19 on the lungs: A triad of PET scans for perfusion, inflammation and tissue remodeling
    Olivia Wegrzyniak, Olof Eriksson, Emil Ekbom, Robert Frithiof, Michael Hultström, Mark Lubberink, Andrei Malinovchi, Jonathan Sigfridsson, Irina Velikyan, Viola Wilson et al. · 2025 · medRxiv
  76. Research Progress on the Correlation between Endocrine Abnormalities in Different Phenotypes of Polycystic Ovary Syndrome
    纯玮 李 · 2025 · Advances in Clinical Medicine
  77. The value of fibroblast growth factor 21 in health and pathology
    Y. Akhverdyan, E. Papichev, B. V. Zavodovsky, Yu. V. Polyakova, L. E. Seewordova, Рожкова Екатерина Сергеевна · 2025 · Сибирский журнал клинической и экспериментальной медицины
  78. Elevated Serum Tsukushi Levels and Their Association with Glycolipid Metabolism in Gestational Diabetes Mellitus Patients
    Xiaoming Wu, Jue Jia, Xia Deng, Xiaoyan Ma, Guoyue Yuan, Ling Yang, Haoxiang Li · 2025 · Diabetes Metabolic Syndrome and Obesity
  79. Bases moleculares de las alteraciones del tejido adiposo y cambios metabólicos asociados al síndrome lipodistrófico en pacientes infectados por HIV-1
    Gallego Escuredo, José Miguel · 2012 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  80. Association between gestational weight gain and metabolic and inflammatory biomarkers in the ETCHED cohort
    Sourav RoyChoudhury, Rachel Caballero, Dorota Wasak, Yunhua L. Muller, Zaqueena Coleman, William C. Knowler, Robert L. Hanson, Marilyn Q. Sale, Madhumita Sinha · 2026 · Scientific Reports
  81. Increased fibroblast growth factor 21 is associated with metabolic syndrome in chronic spinal cord injury: A cross-sectional study
    Sintip Pattanakuhar, Nattayaporn Apaijai, Nipon Chattipakorn, Siriporn Chattipakorn · 2026 · Journal of Spinal Cord Medicine
  82. Development of a Hybrid Microfluidic Enzymatic Reactor for Isolation of Protein Structures
    Sofia P. Novikova, Ralina Valshina, Anna V. Polidauskaite, Polina D. Petrova, Yu. V. Cheburkin, Nikita O. Sitkov · 2026
  83. Fibroblast Growth Factor 21 and Cardiometabolic Risk Markers in Metabolically Healthy and Unhealthy Obese Children
    Can Kurşun, Zühal Örnek, Berrak Güven, Banu Alıcıoğlu · 2026 · Journal of Paediatrics and Child Health
  84. Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
    Aya Abdul-Wahed · 2012
  85. La microalgue Odontella aurita prévient l'insulino-résistance et l'inflammation hépatiques induites par un régime hyper-lipidique : mise en évidence des mécanismes insulino-sensibilisateurs des acides gras polyinsaturés omega-3 au niveau neuronal.
    Hamza Amine · 2016
  86. Homéostasie des céramides et hépatopathies métaboliques
    Marion Régnier · 2018 · theses.fr (ABES)
  87. Formes monogéniques de lipomatose de Launois-Bensaude : étude clinique et moléculaire, et modélisation cellulaire
    Émilie Capel · 2019
  88. Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
    Sarra Smati · 2019 · theses.fr (ABES)
  89. Fonction de la signalisation de l'insuline dans le foie : impact sur la régulation de l'horloge circadienne et le dimorphisme sexuel de l'homéostasie glucidique
    Tiffany Fougeray · 2020 · theses.fr (ABES)
  90. Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
    Mada Ghanem · 2023 · theses.fr (ABES)
  91. Étude et modulation des mécanismes contrôlant la résolution de la fibrose du tissu adipeux au cours de l’obésité et de la perte de poids
    Clémentine Rebière · 2024 · theses.fr (ABES)
  92. Metabolic Syndrome Is Associated with Increased Plasma Fibroblast Growth Factor 21 (FGF21) in Postmenopausal Breast Cancer Survivors: Implications for Therapy and Diagnosis
    Pedro Céspedes, Cristina Buigues, María Dolores Torregrosa, Francisco Miguel Martínez‐Arnau, Omar Cauli, Isabel Trapero · 2026 · Pathophysiology
  93. Efficiency of afamin and fibroblast growth factor 21 for early prediction of gestational diabetes mellitus
    Abdelrahman O. Sabri, Mostafa M. Elhady, Eman H. A. Hemida, Radwa Mansour Mohamed Zaki, Amani F. H. Noureldeen · 2026 · Scientific Reports
  94. Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
    Zara Siu Wa Chui, Yaqian Xue, Xiaoping Wu, Aimin Xu · 2026 · Pharmacological Reviews
  95. Exercise-induced change in FGF21 and adiponectin and their association with metabolic syndrome in older women: a randomized controlled trial
    Liangliang Li, Deokhwa Jeong, Hyeongmo Jeong, Jiye Choi, Sunghwun Kang · 2026 · The journal of nutrition health & aging
  96. FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance
    Qing Shen, Hailan Zou, Leigang Jin, Jiaxin Liu, Shixiang Wang, Na Li, Runhong Zhou, Ming Yue, Baile Wang, Ranyao Yang et al. · 2026 · Cell Metabolism
  97. Fibroblast growth factor 21 in metabolic dysfunction-associated steatotic liver disease and beyond: from bench to bedside
    Hak-Keith Leung, Guo-Jeng Tan, Wei‐Kei Wong, Farahani Khamis, Shamsul Mohd Zain, Wah‐Kheong Chan · 2026 · Hepatoma Research
  98. Adipokine in Metabolic Liver Disease: Adipo–Brain–Liver Cross talk
    苏喻乐, Yiping Yang, Wenjuan Sun, Zhouxi Yu, Yilin Wang, 刘世新, Ziyi Chen, Yanfei Li, Xi Yang, Junyan Liu et al. · 2026 · International Journal of Endocrinology
  99. The relationship between serum FGF-21, neuregulin-4 and leptin levels and disease severity in patients with psoriasis
    Gözde Ulutaş Demirbaş, Fatma Tunçez Akyürek, Fıkret Akyürek · 2026 · Cutaneous and Ocular Toxicology
  100. Perinatal Changes in Serum Fibroblast Growth Factor 21 and Their Association With Postpartum Insulin Resistance in Women With Gestational Diabetes Mellitus
    Yosuke Suzuki, Akihito Morita, Jun Okaniwa, Ayuko Tanaka, 祐子 長谷川, Tatsuya Sato, Daisuke Higeta, Akira Iwase · 2026 · Journal of obstetrics and gynaecology research